Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Stocks
Currencies
Cryptocurrencies
Metals
Indices
Commodities
ETFs
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
News
Top Providers News
Top Providers News
Symbols
Market
Provider
Time
Symbols
News
Provider
2026.10.26
Goldman Sachs Initiates Coverage On Accelevation Holdings with Buy Rating, Announces Price Target of $22
Benzinga
2026.10.26
5 Stock Picks Last Week From Wall Street's Most Accurate Analysts
Benzinga
2026.10.26
BMO Capital Initiates Coverage On FirstEnergy with Outperform Rating, Announces Price Target of $50
Benzinga
2026.10.26
NBIS Stock Falls Pre-Market as Nebius CEO Echoes Elon Musk's Neocloud Financing Concerns: 'Some of the Capital Sources Are Temporarily Closed'
Benzinga
2026.10.26
'Black Swan' Author Nassim Taleb Says AI Will Trigger a ‘Collapse in Hiring’ Before Mass Layoffs: ‘Existing Jobs Are Sticky’
Benzinga
2026.10.26
Why Surgery Partners Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Benzinga
2026.10.26
What Did Jack Dorsey Mean by “There Is No Moat”? Elon Musk and Michael Saylor Weigh In
BeInCrypto
2026.10.26
Apple's Design Team Didn't Want Touchscreen Macs, But Tim Cook and John Ternus Had Other Ideas: Report
Benzinga
2026.10.26
Senator Thom Tillis Warns Trump’s Healthcare Cuts Are Coming ‘Too Soon,’ Could Become 2029 Election Issue, Highlights 'Problematic' Provisions
Benzinga
2026.10.26
Michael Burry Backs Ken Griffin on AI Bubble Concerns, Says GPU Overcapacity Warning Is Obvious to Anyone With a ‘Working Brain Cell’
Benzinga
2026.10.26
Honeywell Technologies Debuts Forge Plant Cognition At Dangote’s Lekki Refinery, Estimating More Than 29 Cents A Barrel In Operational Benefit, Or Over $60M Per Year At Full Capacity
Benzinga
2026.10.26
Iran Hits Back At Marco Rubio’s ‘Pirates of the Caribbean’ Remark, Reminds Him Trump Proudly Said US Was ‘Sort of Like Pirates’
Benzinga
2026.10.26
Is Your Passport Wallet Safe? What Foundation Says About the Phishing Emails
BeInCrypto
2026.10.26
Robert Reich Says Elon Musk’s SpaceX and Starlink Should Become Publicly Owned, Musk Fires Back: ‘Stealing Companies Is a Serious Crime'
Benzinga
2026.10.26
Bristol Myers Squibb, SystImmune’s Iza-Bren Hits Primary Endpoint In Phase 3 PANKU-Lung01 Interim Analysis, Median PFS 11.1 Versus 5.7 Months (HR 0.40) Over Platinum Chemotherapy In EGFR-Mutated NSCLC
Benzinga
2026.10.26
Vitalik Buterin Backs AI Model That Deliberately Cut Its Hacking Skills
BeInCrypto
2026.10.26
Reported Saturday, GSK’s Jemperli Monotherapy Shows Generally Consistent Safety, With Serious Adverse Reactions In 20% And Discontinuations In 3%, Alongside 76% Complete Response In Phase II AZUR-1 MSI-H/dMMR Rectal Cancer Trial
Benzinga
2026.10.26
'Something We Haven't Seen Before': Bitcoin and Gold Are the Two Worst-Performing Assets of 2026
Benzinga
2026.10.26
Reported Sunday, Genentech’s Divarasib Lowers Death Risk 44% In Phase III Krascendo 1 With Fewer TRAE Discontinuations (4.8% Versus 11.7%) Than Sotorasib Or Adagrasib In Previously Treated KRAS G12C NSCLC
Benzinga
2026.10.26
Anthropic’s Claude Reportedly Bypassed Georgia Vote-Data Paywall, Prompting New AI Safeguard Concerns Ahead of Midterms
Benzinga
2026.10.26
Reported Friday, Travere Says PROTECT Biomarker Data Add To Superior Proteinuria Reduction, Slower Kidney Function Decline Versus Irbesartan, Supporting FILSPARI As Non-Immunosuppressive, Kidney-Targeted, Foundational First-Line Treatment For IgA...
Benzinga
2026.10.26
Reported Saturday, Lilly Presented First Phase 1 Data For Sofe-M Plus Bevacizumab In Platinum-Sensitive Ovarian Cancer: 79% Confirmed Objective Response Rate, 100% Disease Control Rate, Activity Across FRα Expression Levels
Benzinga
2026.10.26
Moderna CEO Says Cancer Vaccine Could Work Beyond Melanoma But Shares Still Slip
BeInCrypto
2026.10.26
Reported Saturday, Immatics Reports IMA203CD8 Cell Therapy 51% ORR, 41% cORR Across Multiple Solid Tumors With Manageable Safety; IMA402 Bispecific Shows 32% cORR In PRAME-High Melanoma, Favorable Safety Profile
Benzinga
2026.10.26
Reported Saturday, Incyte To Co-Fund Genmab’s Phase 1/2 Study Of Petosemtamab Combination In First-Line KRAS G12D-Mutated Metastatic Colorectal Cancer, Provide INCB161734 Clinical Supply
Benzinga
2026.10.26
AstraZeneca Announced Saturday,Perioperative IMFINZI Plus Neoadjuvant Enfortumab Vedotin Cuts Recurrence Risk 49%, Death Risk 42% Versus Standard Of Care In Muscle-Invasive Bladder Cancer Patients Ineligible For Or Refusing Cisplatin, VOLGA Phase III
Benzinga
2026.10.26
Marjorie Taylor Greene Says Health Insurance Is ‘an Unaffordable Disaster’ and Republicans ‘Have Not Even Attempted to Fix It’
Benzinga
2026.10.26
AstraZeneca Announced Saturday, IMFINZI Plus Tarlatamab-dlle Cuts Death Risk 58% Versus IMFINZI Alone In First-Line Extensive-Stage Small Cell Lung Cancer, Median OS 21.1 Versus 12.7 Months, In DeLLphi-305 Phase III
Benzinga
2026.10.26
Reported Saturday, Pfizer Presents Phase 2 25vPnC Infant Data At IDWeek 2026: Robust Responses To All 25 Serotypes, Including Five New, Safety Comparable To PREVNAR 20, No Related Serious Adverse Events
Benzinga
2026.10.26
Verizon, Celestica and 3 Stocks to Watch Heading Into Monday
Benzinga
1
...
527
528
529
530
531
532
...
709
>